Skip to main content
. Author manuscript; available in PMC: 2016 May 5.
Published in final edited form as: N Engl J Med. 2015 Nov 5;373(19):1835–1844. doi: 10.1056/NEJMoa1505237

Figure 1. Progression-free Survival.

Figure 1

Panel A shows the probability of progression-free survival among the 36 patients who could be evaluated. Panel B shows the probability of progression-free survival according to the baseline score on the Mantle Cell Lymphoma International Prognostic Index (MIPI) — lower than 6.2 (indicating low-risk or intermediate-risk disease) versus 6.2 or higher (indicating high-risk disease).